21259 ⎘
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
#302PREPARATION INCLUDING VACCINE ADJUVANT
#303PATCH
#304Compositions with permeation enhancers for drug delivery
#305FORMULATION AND AEROSOL CANISTERS, INHALERS, AND THE LIKE CONTAINING THE FORMULATION
#306SEMIFLUORINATED ALKANE COMPOSITIONS COMPRISING OMEGA-3 FATTY ACID ETHYL ESTERS
#307IRON FORMULATIONS FOR TOPICAL ADMINISTRATION AND METHODS OF TREATMENT OF IRON DEFICIENCY
#308Pharmaceutical combinations for the treatment of cancer
#309TOPICAL COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY SKIN DISEASES
#310Anhydrous antimicrobial topical formulations and methods of use thereof
#311Therapeutic agent for phosphodiesterase inhibition and its related disorders
#312TRANS-RESVERATROL TOPICAL MEDICATION FOR THE TREATMENT OF PAIN AND METHOD OF MANUFACTURE THEREOF
#313FORMULATION OF ACOUSTICALLY ACTIVATABLE PARTICLES HAVING LOW VAPORIZATION ENERGY AND METHODS FOR USING SAME
#314METHOD OF ENCAPSULATING ACTIVE INGREDIENTS IN LIPOSOMES
#315PETROLATUM-BASED COMPOSITIONS AND METHODS OF TREATMENT FOR ONYCHOMYCOSIS
#316PETROLATUM-BASED DELIVERY SYSTEMS AND FOR ACTIVE INGREDIENTS
#317Transdermal Patch Containing Fentanyl as Active Ingredient
#318UMECLIDINIUM AND VILANTEROL FORMULATION AND INHALER
#319Petrolatum-based PHMB compositions and methods of treatment for onychomycosis
#320Topical roflumilast formulation having improved delivery and plasma half life
#321PHARMACEUTICAL COMPOSITION
#322PHARMACEUTICAL COMPOSITIONS COMPRISING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION
#323COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF RADIATION DERMATITIS, ECZEMA, BURNS, WOUNDS AND CERTAIN CANCERS
#324PHARMACEUTICAL FORMULATION CONTAINING REMDESIVIR AND ITS ACTIVE METABOLITES FOR DRY POWDER INHALATION
#325METHOXYCHALCONE DERIVATIVES AND USES THEREOF
#326WATER-SOLUBLE, FULL-SPECTRUM, CANNABIS COMPLEX AND METHOD OF PRODUCTION
#327Composition for external use on skin for inflammatory diseases
#328Selenium disulfide compositions for use in treating meibomian gland dysfunction
#329TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME
#330Compositions comprising milk fat globules and methods of making same
#331COMPOSITIONS WITH SYNERGISTIC PERMEATION ENHANCERS FOR DRUG DELIVERY
#332ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPENE BLEND AND METHODS OF USE THEREOF
#333MODULATORS OF PROSTATE-SPECIFIC G-PROTEIN RECEPTOR (PSGR/OR51E2) AND METHODS OF USING SAME
#334STABLE PHARMACEUTICAL COMPOSITIONS FOR PRESSURIZED METERED DOSE INHALERS
#335Methods and Compositions for Treating Meibomian Gland Dysfunction
#336Methods and compositions for treating meibomian gland dysfunction
#337METHODS FOR TREATING ACNE
#338Method for treatment of a viral-mediated infectious disease
#339OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY
#340Pharmaceutical combinations for the treatment of cancer
#341PREPARATION OF A SINGLE-SURFACTANT MICROEMULSION
#342Prostacyclin compounds, compositions and methods of use thereof
#343LDL-CHOLESTEROL-LOWERING CELL EXTRACT AND FOOD SUPPLEMENT
#344ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION
#345Hydrogel composition comprising a crosslinked polymer
#346Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#347Transdermal delivery of cannabidiol
#348ANTIVIRAL PREPARATION FOR TREATING HUMAN SKIN
#349ANTIVIRAL PREPARATION FOR TREATING HUMAN SKIN
#350STABILIZED HYALURONIC ACID
#351NOVEL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES
#352Chlorogenic acid-containing composition for nasal administration
#353PHARMACEUTICAL COMPOSITION COMPRISING SALBUTAMOL
#354Cannabinoid and menthol transdermal delivery systems and methods
#355PIGMENT-LOADED SOLID LIPID NANOPARTICLES
#356Oxadiazole compounds
#357Topical compositions for the treatment of dermatological disorders
#358Phospholipid compounds and formulations
#359Compositions and dosage forms for oral delivery
#360THIENO[2,3-B]PYRIDINE DERIVATIVES AS EPAC INHIBITORS AND THEIR PHARMACEUTICAL USES
#361HEALTH-CARE PRODUCT COMPOSITION FOR ENRICHING ASTHENIC DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF
#362New Medical Devices, Delivery Vehicles and Manufacturing Thereof
#363METHOD FOR REDUCING SKIN SENSITIZATION OF AN ASENAPINE-CONTAINING PATCH
#364TOPICAL COMPOSITIONS COMPRISING VIABLE PROBIOTIC BACTERIA
#365BIPHASIX CANNABINOID DELIVERY
#366Petrolatum-based delivery systems and for active ingredients
#367STERILE TOPICAL SALINE PUTRESCINE FORMULATION AND USES THEREOF
#368Wound care formulations with clinically effective active ingredient content
#369SYNERGISTIC NEUTRACEUTICAL FORMULATIONS
#370Compositions, Methods and/or Devices for Prevention and/or Treatment of Dry Eye Disorders
#371Compositions and methods for treating rosacea and acne
#372CONTAINER SYSTEM AND PHARMACEUTICAL FOAM COMPOSITION COMPRISING BETAMETHASONE
#373Topical compositions and methods for treating inflammatory skin diseases
#374Petrolatum-based compositions comprising cationic biocides
#375METHOTREXATE TOPICAL SOLUTION FOR TREATMENT OF PSORIASIS
#376Fleece for oral product with releasable component
#377Method of encapsulating active ingredients in liposomes
#378Topical treatment for animals
#379Thylakoid extract composition and formulation for the treatment of inflammatory bowel disease
#380PHARMACEUTICAL SPRAY COMPOSITION COMPRISING A VITAMIN D ANALOGUE AND CORTICOSTEROID
#381Interactional Biosystem
#382IONIC LIQUID COMPOSITIONS FOR TREATMENT OF ROSACEA
#383Composition for increasing the expression of a growth factor gene, comprising coreshell structured microparticles as active ingredient
#384PLANT-BASED NERIUM OLEANDER EXTRACTS AND METHODS
#385NON-IRRITATING TESTOSTERONE EMULSIONS
#386Paraffin wax with CBD isolate
#387Pharmaceutical compositions comprising nebivolol
#388Delivery of drug nanoparticles and methods of use thereof
#389Topical pharmaceutical composition based on semifluorinated alkanes
#390Treatment of erectile dysfunction and other indications
#391METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA
#392BIOMARKERS FOR ANTIBODY-DRUG CONJUGATE MONOTHERAPY OR COMBINATION THERAPY
#393Topical antibiotic
#394TOPICAL OINTMENT FORMULATIONS OF PDE-4 INHIBITOR AND THEIR USE IN TREATING SKIN CONDITIONS
#395Arylamide compounds and compositions and uses thereof
#396Liquid Protein Formulations Containing Viscosity-Lowering Agents
#397Dosage delivery film
#398PUFA SALT FORMULATIONS (II)
#399COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF CANNABINOIDS AND TERPENOIDS
#400COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#401Combination of a retinoid and an extract of (L.) gaertn
#402Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
#403Temperature-controlled semiochemical composition diffusers
#404TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#405SKIN OINTMENT FOR TREATING LABIA MINORA SKIN
#406Dissolved C60 and method of producing dissolved C60
#407METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING SKIN BARRIER DISRUPTIONS
#408Self-emulsifying formulations of DIM-related indoles
#409Liquid protein formulations containing cyclic adenosine monophosphate (cAMP) or adenosine triphosphate (ATP)
#410SOLID OILY EXTERNAL COMPOSITION
#411Humanized and de-immunized antibodies
#412Liquid protein formulations containing 4-ethyl-4-methylmorpholinium methylcarbonate (EMMC)
#413Porous carbon material composites and their production process, adsorbents, cosmetics, purification agents, and composite photocatalyst materials
#414SURFACTANT-FREE, WATER-FREE FOAMABLE COMPOSITION AND BREAKABLE FOAMS AND THEIR USES
#415HYDROCARBON / LIPID - CAROTENOID COMPLEXES
#416Ophthalmic compositions comprising ciclosporin
#417Anti-infective methods, compositions, and devices
#418COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#419SURFACTANT-FREE WATER-FREE FOAMABLE COMPOSITIONS, BREAKABLE FOAMS AND GELS AND THEIR USES
#420TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
#421Topical formulation for a JAK inhibitor
#422Aerosol formulation for COPD
#423Topical therapy for the treatment of cervical intraepithelial neoplasia (CIN) and cervical cancer using nanoparticles of taxanes
#424Two-part nitric oxide generating topical compositions
#425Oil-based wound care compositions and methods
#426Pharmaceutical combinations for the treatment of cancer
#427Lipid emulsified drug delivery systems for chemoprevention and treatment
#428Lamotrigine oral liquid suspension and use thereof
#429Topical formulation for a JAK inhibitor
#430Nutritional composition
#431O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#432Methods for treating pain associated with sickle cell disease
#433PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#434Sustained-release 9-cis retinoic acid implantable drug delivery pellets for the prevention of postsurgical edema and lymphedema
#435A topical herbal healing formulation
#436Petrolatum-based delivery systems and for active ingredients
#437Topical medicaments
#438WOUND CARE FORMULATIONS WITH CLINICALLY EFFECTIVE INGREDIENT CONTENT
#439METHODS FOR THE TREATMENT OF DEPRESSION
#440ABIRATERONE ACETATE LIPID FORMULATIONS
#441TOPICAL FORMULATION FOR INFLAMMATORY SKIN CONDITIONS
#442METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER
#443COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS USING SAME
#444Method of treating, reducing, or alleviating a medical condition in a patient
#445METAL OXIDE AND POLYMER CONTROLLED DELIVERY SYSTEMS, SUNSCREENS, TREATMENTS AND TOPICAL COATING APPLICATORS
#446COMPOSITIONS AND METHODS FOR TOPICAL DELIVERY OF PROSTAGLANDINS TO SUBCUTANEOUS FAT
#447Selenium disulfide compositions for use in treating meibomian gland dysfunction
#448COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#449Topical phenytoin for use in the treatment of peripheral neuropathic pain
#450Heterocyclic amides as kinase inhibitors
#451Combination Therapy for Cancer Treatment
#452Petrolatum-based compositions comprising cationic biocides
#453Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
#454Topical tetracycline compositions
#455Nanoparticles for selective death of cancer cells through ferroptosis, method of preparing the same, and use of the nanoparticles
#456ANHYDROUS POLYSACCHARIDE FILMS
#457COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#458ADJUNCTIVE THERAPY WITH 25-HYDROXYVITAMIN D
#459TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#460Modulators of prostate-specific g-protein receptor (PSGR/OR51E2) and methods of using same
#461Semifluorinated alkane compositions
#462Treating erectile dysfunction via an herbal compostion at the navel area
#463Treatment of erectile dysfunction and other indications
#464THE TRANSDERMAL USE OF CYANOBACTERIAL ALGAE, AND/OR EXTRACTS THEREOF, VIA LOW OR HIGH INTENSITY TRANSPORATION DEVICES FOR BEAUTY AND HEALTH ENHANCING PURPOSES
#465Methods and compositions for treating skin
#466Ophthalmic suspension composition
#467Pharmaceutical composition for treatment of increased intraocular pressure
#468TOPICAL PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST AMITRIPTYLINE, FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
#469METHODS FOR THE TREATMENT OF DEPRESSION
#470Cannabis-Based Extracts and Topical Formulations for Use in Skin Disorders
#471Compositions comprising mixtures of semifluorinated alkanes
#472Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
#473Personal Care Composition With Increased Vapor Release
#474Prophylactic protection against viral infections
#475THIOL AND DISULFIDE-CONTAINING AGENTS FOR INCREASING MEIBOMIAN GLAND LIPID SECRETION
#476Methods for Accelerated Return of Skin Integrity and for the Treatment of Impetigo
#477Methods for preventing and treating pneumocystis infections
#478Topical roflumilast formulation having improved delivery and plasma half life
#479Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives
#480Petrolatum-based PHMB compositions and methods of treatment for onychomycosis
#481Petrolatum-based compositions and methods of treatment for onychomycosis
#482Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract
#483Iodine compositions
#484Mucoadhesive gel composition
#485Anti-fibroblastic fluorochemical emulsion therapies
#486Composition for external use on skin for inflammatory diseases
#487LDL-cholesterol-lowering cell extract and food supplement
#488Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#489Topical pharmaceutical compositions
#490OPHTHALMIC TREATMENT COMPOSITION AND VEHICLE FOR DELIVERY OF PHARMACEUTICAL SUBSTANCES OR THERAPEUTIC AGENTS
#491Methods and compositions for eye care
#492Cannabinoid Compositions
#493Combination vaccine for swine
#494COMPOSITION AND METHOD FOR TREATING ITCHING, BURNING AND DISCOMFORT OF THE SKIN
#495PHARMACEUTICAL FORMULA FOR THE TREATMENT AND/OR PREVENTION OF ARTHRITIS AND ITS MANUFACTURE
#496Prostacyclin compounds, compositions and methods of use thereof
#497Retinol oil composition
#498Formulation and aerosol canisters, inhalers, and the like containing the formulation
#499SIROLIMUS CONTAINING COMPOSITIONS
#500Delivery of drug nanoparticles and methods of use thereof
#501Methods for preparing squalene
#502MEDICAMENT FOR THE TREATMENT OF VIRAL SKIN AND TUMOUR DISEASES
#503Biosourced gelled composition of hydrocarbon oil and gelling polymer
#504NANOEMULSION COMPRISING IMIDAZOQUINOLINE-BASED MATERIAL AND USE THEREOF
#505Topical formulation for a JAK inhibitor
#506TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#507ANTIMICROBIAL COMPOSITIONS AND METHODS
#508Ophthalmic compositions comprising ciclosporin
#509Therapeutic agent for phosphodiesterase inhibition and its related disorders
#510Topical tetracycline compositions
#511Compositions and methods for treating rosacea and acne
#512COMPOSITIONS AND METHODS OF CONTROLLING EXPRESSION OF THERMOGENIN (UCP-1) IN SKELETAL MUSCLES
#513Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid
#514PHARMACEUTICAL COMPOSITION
#515Cracking aerosol composition
#516COMBRETUM LAURIFOLIUM MART. EXTRACT AND METHODS OF EXTRACTING AND USING SUCH EXTRACT
#517Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
#518Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroid
#519Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroid
#520PHARMACEUTICAL COMPOSITION
#521Systems and Methods for Delivery of Nitric Oxide
#522HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF
#523COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA
#524Topical composition
#525SUSPENSIONS OF CYCLOSPORIN A FORM 2
#526PATCH
#527SOLUBILIZED COQ-10
#528Fenoldopam topical formulations for treating skin disorders
#529COMPOSITIONS COMPRISING TACROLIMUS FOR THE TREATMENT OF INTRAOCULAR INFLAMMATORY EYE DISEASES
#530Topical formulations efficacious for wound care
#531Formulations for solubilizing hormones
#532CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#533Personal lubricant disk
#534Arylamide compounds and compositions and uses thereof
#535Methods and compositions particularly for treatment of attention deficit disorder
#536Topical Pharmaceutical Formulations For Treating Inflammatory-Related Conditions
#537TETRACYCLINE MANAGEMENT OF EGFR INHIBITOR ASSOCIATED DERMATOSES
#538Pharmaceutical compositions of testosterone
#539Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
#540Compositions, gels and foams with rheology modulators and uses thereof
#541Methods and compositions for modifying the behavior of animals
#542Topical tetracycline compositions
#543Methods and compositions particularly for treatment of attention deficit disorder
#544Dosage delivery film
#545Methods and compositions particularly for treatment of attention deficit disorder
#546Methods and compositions particularly for treatment of attention deficit disorder
#547Prostacyclin compounds, compositions and methods of use thereof
#548Methods of applying active components
#549Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
#550COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES
#551Pharmaceutical composition for treatment of increased intraocular pressure
#552Compositions, gels and foams with rheology modulators and uses thereof
#553TRAZODONE AND TRAZODONE HYDROCHLORIDE IN PURIFIED FORM
#554CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#555O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES
#556Mupirocin cream in pump device
#557COMPOSITIONS AND METHODS FOR TREATING ALOPECIA
#558Anhydrous polysaccharide films
#559Treatment compound and method of application for hoof or foot disease in animals
#560Anti-infective methods, compositions, and devices
#561Multi-phase liquid composition, device for measuring permeability of drugs, and method for measuring permeability of drugs
#562Topical pharmaceutical compositions
#563Topical pharmaceutical compositions
#564SOLUBILIZED COQ-10
#565Pheromone compositions for stimulating early onset of estrus and reducing labor needs in breeding peri-pubertal suids and methods of use
#566Methods and compositions particularly for treatment of attention deficit disorder
#567Methods and compositions particularly for treatment of attention deficit disorder
#568Topical therapy for the treatment of skin malignancies using nanoparticles of taxanes
#569Method of preparing a pharmaceutical composition
#570NON-MEDICATED, TEETHING, COOLING COMPOSITION
#571TOPICAL COMPOSITIONS COMPRISING A CORTICOSTEROID
#572PARTICULATE MATERIALS
#573TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TISSUE DAMAGE
#574CANNABIS-BASED THERAPEUTIC PRODUCT FOR TREATMENT OF CHRONIC PAIN
#575Inhalers and Related Methods
#576Autophagy activation-induced compound for improving skin inflammation for aging
#577Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surface
#578Cannabinoid Compositions
#579Topical pharmaceutical compositions
#580Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
#581Method of reducing stress and anxiety in equines
#582Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#583Pharmaceutical compositions
#584Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
#585Topical tetracycline compositions
#586Topical formulations of PDE-4 inhibitors and their methods of use
#587Phenol compound and combination of same with a benzodiazepine fused to 1,4-dihydropyridine for treating diseases of the central nervous and vascular systems
#588Topical compositions and methods for treating skin diseases
#589Topical compositions for improved delivery of active agents
#590Patch and method for producing the same
#591Topical medicament for skin and mucosal injuries
#592ADHESIVE PATCH
#593Cationic oil-in-water emulsions
#594Compositions and methods for treating pruritis ani and anal fissures
#595Method of Making a Soft Gel Capsule Comprising COQ-10 Solubilized in a Monoterpene
#596Oil foamable carriers and formulations
#597CANNABINOID FORMULATIONS AND METHODS INCLUDING THE ANTIOXIDANT C60
#598Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives
#599Treatment of erectile dysfunction and other indications
#600Oil-in-water emulsions including retinoic acid